Stockreport

Albireo's odevixibat shows encouraging action in mid-stage study [Seeking Alpha]

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF Albireo's odevixibat shows encouraging action in mid-stage study Albireo Pharma (NASDAQ: ALBO announces Pediatric cholestasis patients treated with odevixibat, an ileal [Read more]